Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CPXX

(CPXX) (CPXX) Stock Price, News & Analysis

(CPXX) logo

About (CPXX) Stock (NASDAQ:CPXX)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$30.24
$30.24
50-Day Range
N/A
52-Week Range
$1.12
$30.36
Volume
N/A
Average Volume
2.62 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's product, VYXEOS, a nano-scale liposomal formulation of cytarabine:daunorubicin, in Phase III clinical testing for the treatment of acute myeloid leukemia. The Company also conducted clinical development efforts on CPX-1, a nano-scale liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer; and has a preclinical stage product candidate CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation. The Company operates in the United States and Canada.

Remove Ads
Receive CPXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CPXX) and its competitors with MarketBeat's FREE daily newsletter.

CPXX Stock News Headlines

Partner with Elon Musk on Project Colossus… Before May 1st
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Headlines

CPXX Stock Analysis - Frequently Asked Questions

(CPXX) (NASDAQ:CPXX) announced its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that (CPXX) investors own include Sophiris Bio (SPHS), Consolidated Water (CWCO), Anavex Life Sciences (AVXL), Alder Biopharmaceuticals (ALDR), Fc Global Realty (FCRE), Chipotle Mexican Grill (CMG) and Immunomedics (IMMU).

Company Calendar

Last Earnings
5/10/2016
Today
4/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CPXX
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CPXX) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners